$-0.03 EPS Expected for ShoreTel (SHOR); Enanta Pharmaceuticals Has 1.47 Sentiment

July 12, 2017 - By Marguerite Chambers

Analysts expect ShoreTel Inc (NASDAQ:SHOR) to report $-0.03 EPS on August, 3.They anticipate $0.06 EPS change or 200.00% from last quarter’s $0.03 EPS. After having $-0.02 EPS previously, ShoreTel Inc’s analysts see 50.00% EPS growth. About 371,653 shares traded. ShoreTel Inc (NASDAQ:SHOR) has declined 1.14% since July 12, 2016 and is downtrending. It has underperformed by 17.84% the S&P500.

Enanta Pharmaceuticals, Inc. is a research and development-focused biotechnology company. The company has market cap of $740.44 million. The Firm uses chemistry-driven approach and drug discovery solutions to create small molecule drugs for the treatment of viral infections and liver diseases. It currently has negative earnings. The Company’s research and development programs are focused on three disease targets: non-alcoholic steatohepatitis / primary biliary cholangitis (PBC), respiratory syncytial virus (RSV) and hepatitis B virus (HBV).

Krensavage Asset Management Llc holds 12.68% of its portfolio in Enanta Pharmaceuticals Inc for 1.06 million shares. Great Point Partners Llc owns 828,253 shares or 5.7% of their US portfolio. Moreover, Mcclain Value Management Llc has 4.8% invested in the company for 116,153 shares. The New York-based Armistice Capital Llc has invested 1.81% in the stock. Hays Advisory Llc, a Tennessee-based fund reported 116,939 shares.

About 145,744 shares traded. Enanta Pharmaceuticals Inc (ENTA) has risen 40.91% since July 12, 2016 and is uptrending. It has outperformed by 24.21% the S&P500.

Since April 30, 2017, it had 0 insider purchases, and 1 sale for $8,193 activity. Corrales Eugenia sold 1,250 shares worth $8,193.

Investors sentiment decreased to 0.63 in 2016 Q4. Its down 1.05, from 1.68 in 2016Q3. It worsened, as 18 investors sold ShoreTel Inc shares while 64 reduced holdings. 22 funds opened positions while 30 raised stakes. 53.07 million shares or 3.96% less from 55.25 million shares in 2016Q3 were reported. Blackrock Institutional Tru Na reported 2.06M shares stake. Highbridge Capital Ltd Com invested 0.01% of its portfolio in ShoreTel Inc (NASDAQ:SHOR). Blackrock Japan Communications holds 0% or 812 shares. Franklin Resource accumulated 1.44 million shares. Blackrock Advisors Limited Liability Company reported 420,321 shares. Kennedy Capital has 1.26 million shares. Rgm Capital Limited Liability Co holds 3.43% or 4.40M shares. 306,822 are held by Morgan Stanley. Alliancebernstein Lp holds 0% in ShoreTel Inc (NASDAQ:SHOR) or 66,010 shares. Art Advsr Ltd Liability owns 40,200 shares for 0.02% of their portfolio. Ny State Common Retirement Fund, a New York-based fund reported 441,387 shares. State Bank Of Ny Mellon reported 0% stake. State Of Wisconsin Invest Board stated it has 0.01% in ShoreTel Inc (NASDAQ:SHOR). Clearline L P reported 452,971 shares stake. Penn Cap Mgmt Commerce invested in 2.26 million shares or 1.03% of the stock.

ShoreTel, Inc. is a provider of business communication solutions. The company has market cap of $385.76 million. The Firm is engaged in the design, development, marketing and sale of business communication solutions. It currently has negative earnings. The Firm is focused on the small and medium sized businesses seeking a unified communications solution allowing them to communicate anytime, anyplace and through any device they chose.